.png){kind=icon}
返回
Therapy for CPPD: Options and Evidence
.png){kind=icon}
PRE
AI
DOI：10.1007/s11926-018-0739-z.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Purpose of Review Current evidence and accumulated experience for the management of calcium pyrophosphate deposition disease (CPPD) are presented. Recent Findings Contrary to other rheumatic inflammatory conditions that account for high interest and growing research, advances in treating CPPD are still very limited and mostly derive from those achieved in gout. Summary Once formed, calcium pyrophosphate crystals cannot be dissolved; therefore, management relies on the control of crystal-derived inflammation. Besides classical agents-such as colchicine, glucocorticoids, or NSAIDs-the use of targeted therapies, mostly against interleukin-1, has provided a relevant relief for refractory CPPD patients in recent years. Meanwhile. former enthusiasm about conventional disease-modifying agents such as methotrexate is currently controversial.
Keyword:
Calcium pyrophosphate
Chondrocalcinosis
Therapy
Colchicine
Methotrexate
Anakinra
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.9
论文数:
1.1K
被引数:
4.3K
机构
引用论文
A facile one-step way to anchor noble metal (Au, Ag, Pd) nanoparticles on a reduced graphene oxide mat with catalytic activity for selective reduction of nitroaromatic compounds.png)
CrystEngComm
CrystEngCommIF0
PREAI
分享收藏Framing digital disconnection: Problem definitions, values, and actions among digital detox organisers数字疏离的框架：数字排毒组织者在问题定义、价值观和行动方面的研究
PREAI
分享收藏Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failureJOINT BONE SPINE
JOINT BONE SPINEIF4.3
PREAI
分享收藏
查看更多内容